U 
26.59
+0.11%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥401.3m
FY2017FY2025
Net income
−CN¥76.1m
FY2017FY2025
Free cash flow
CN¥8.6m
FY2017FY2025
Shareholders' equity
CN¥1.12bn
FY2017FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥401.3m | CN¥665.6m | CN¥498.2m | CN¥549.8m | CN¥517.2m | CN¥626.6m | CN¥620.8m | CN¥692.1m | CN¥583.2m |
| Gross profit | CN¥78.9m | CN¥95.6m | CN¥111.7m | CN¥150.3m | CN¥151.4m | CN¥161.7m | CN¥193.8m | CN¥181.2m | CN¥171.4m |
| Research and development | CN¥19.1m | CN¥19.7m | CN¥20.7m | CN¥20.9m | CN¥17.3m | CN¥16.3m | CN¥16.0m | CN¥12.3m | CN¥14.1m |
| Operating income | −CN¥13.8m | CN¥7.7m | CN¥37.8m | CN¥80.9m | CN¥97.2m | CN¥98.9m | CN¥128.7m | CN¥120.9m | CN¥101.6m |
| Net income | −CN¥76.1m | CN¥5.0m | CN¥42.4m | CN¥65.1m | CN¥80.7m | CN¥69.5m | CN¥87.3m | CN¥75.3m | CN¥65.2m |
| Diluted earnings per share | -0.54 | 0.03 | 0.36 | 0.56 | 0.99 | 0.84 | 0.62 | 0.54 | 0.46 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.38bn | CN¥1.49bn | CN¥1.66bn | CN¥1.64bn | CN¥901.3m | CN¥797.9m | CN¥821.7m | CN¥740.4m | CN¥660.9m |
| Cash and short-term investments | — | CN¥622.4m | CN¥776.0m | CN¥900.2m | CN¥324.3m | CN¥386.5m | CN¥306.8m | CN¥246.0m | CN¥78.3m |
| Total liabilities | CN¥252.9m | CN¥269.3m | CN¥409.9m | CN¥427.0m | CN¥391.6m | CN¥348.0m | CN¥434.2m | CN¥418.0m | CN¥465.8m |
| Debt | — | CN¥21.3m | CN¥25.9m | CN¥15.5m | CN¥11.5m | CN¥5.6m | CN¥18.3m | CN¥22.9m | CN¥15.0m |
| Shareholders' equity | CN¥1.12bn | CN¥1.21bn | CN¥1.23bn | CN¥1.21bn | CN¥500.9m | CN¥441.0m | CN¥379.2m | CN¥315.3m | CN¥189.7m |
| Shares outstanding | 141m | 172m | 116m | 115m | 82m | 83m | 141m | 141m | 141m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥82.8m | CN¥4.9m | CN¥17.2m | CN¥18.9m | CN¥19.2m | CN¥137.5m | CN¥85.9m | CN¥82.1m | CN¥42.4m |
| Capital spending | −CN¥74.2m | −CN¥21.5m | −CN¥45.7m | −CN¥75.4m | −CN¥62.8m | −CN¥6.2m | −CN¥20.6m | −CN¥5.7m | −CN¥7.9m |
| Free cash flow | CN¥8.6m | −CN¥16.6m | −CN¥28.5m | −CN¥56.6m | −CN¥43.6m | CN¥131.3m | CN¥65.3m | CN¥76.4m | CN¥34.6m |
| Dividends paid | −CN¥12.4m | −CN¥14.2m | −CN¥19.8m | −CN¥40.0m | −CN¥44,735 | −CN¥27.3m | −CN¥20.7m | −CN¥670,881 | −CN¥1.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥53.9m | CN¥73.7m | CN¥106.0m | CN¥97.5m | CN¥104.0m | CN¥93.7m | CN¥232.1m | CN¥273.1m |
| Gross profit | CN¥13.3m | CN¥20.4m | CN¥13.2m | CN¥28.7m | CN¥13.1m | CN¥23.9m | CN¥16.3m | CN¥49.8m |
| Operating income | −CN¥11.2m | CN¥1.8m | −CN¥9.8m | −CN¥5.9m | −CN¥11.3m | CN¥10.3m | −CN¥2.8m | CN¥33.0m |
| Net income | −CN¥9.8m | CN¥1.8m | −CN¥79.7m | −CN¥5.2m | −CN¥3.1m | CN¥11.9m | −CN¥3.7m | CN¥26.2m |
| Diluted earnings per share | -0.07 | 0.01 | -0.57 | -0.04 | -0.02 | 0.08 | -0.02 | 0.15 |
| Cash from operations | — | — | — | −CN¥20.0m | −CN¥13.0m | CN¥56.0m | CN¥33.0m | −CN¥1.0m |
| Capital spending | −CN¥2.0m | −CN¥5.0m | −CN¥29.0m | −CN¥12.0m | −CN¥17.0m | −CN¥14.0m | −CN¥3.0m | −CN¥8.0m |
| Free cash flow | — | — | — | −CN¥32.0m | −CN¥30.0m | CN¥42.0m | CN¥30.0m | −CN¥9.0m |
| Total assets | CN¥1.56bn | CN¥1.52bn | CN¥1.38bn | CN¥1.43bn | CN¥1.48bn | CN¥1.50bn | CN¥1.49bn | CN¥1.57bn |
| Cash and short-term investments | — | — | — | CN¥733.5m | CN¥739.2m | CN¥812.0m | CN¥622.4m | CN¥642.6m |
| Debt | — | — | — | CN¥5.7m | CN¥2.4m | CN¥34.3m | CN¥6.7m | CN¥31.8m |
| Shareholders' equity | CN¥1.14bn | CN¥1.11bn | CN¥1.12bn | CN¥1.21bn | CN¥1.22bn | CN¥1.23bn | CN¥1.21bn | CN¥1.23bn |
Financial ratios
Data as of 4 Nov 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 19.7% | 14.4% | 22.4% | 27.3% | 29.3% | 25.8% |
| Operating margin | -21.2% | 1.4% | 9.2% | 15.4% | 19.2% | 16.3% |
| Net margin | -19.0% | 0.7% | 8.5% | 11.8% | 15.6% | 11.1% |
| Return on equity | -6.8% | 0.4% | 3.5% | 5.4% | 16.1% | 15.8% |
| Return on assets | -5.5% | 0.3% | 2.6% | 4.0% | 9.0% | 8.7% |
| Free cash flow yield | 4.2% | 0.6% | 2.0% | 3.1% | 3.7% | 6.5% |
| Revenue growth | -39.7% | 33.6% | -9.4% | 6.3% | -17.5% | 0.9% |
| Earnings growth | -1637.3% | -88.3% | -34.8% | -19.3% | 16.0% | -20.3% |
| Current ratio | 4.43x | 4.73x | 3.49x | 3.36x | 1.88x | 2.09x |
| Debt to equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.00x | 0.01x |
| Equity ratio | 81.0% | 81.2% | 73.9% | 73.4% | 55.6% | 55.3% |
| Interest coverage | -125.86x | 4.50x | 37.40x | 82.33x | 212.12x | 132.06x |
| R&D as a share of sales | 4.8% | 3.0% | 4.1% | 3.8% | 3.3% | 2.6% |
| Buybacks as a share of market value | 18.3% | -47.7% | -1.1% | -41.1% | 1.3% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -10.0% | -8.5% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 16.4% | 20.6% | 23.0% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | -72.8 | — | 82.3 | 55.0 |
| Price to sales | 13.8 | 6.0 | 7.0 | 6.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 4 years. Last went ex-dividend on 23 Jul 2025.
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Paid in the year | 0.10 | 0.12 | 0.18 | 0.363 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.